RSS-Feed abonnieren
PDF herunterladen
DOI: 10.4103/ajm.AJM_83_18
Human menopausal gonadotropin-induced bioprosthetic valve thrombosis
Authors
Financial support and sponsorship Nil.
Abstract
Bioprosthetic valve thrombosis (BPVT) is a rare but potentially life-threatening complication. Human menopausal gonadotropin (hMG) is commonly used for ovulation induction and has been associated with arterial and venous thrombosis. We reported a case of BPVT related to in vitro fertilization in a 39-year-old female, who underwent redo mitral valve replacement. To the best of our knowledge, this is the first case of hMG-induced BPVT in a young female patient.
Publikationsverlauf
Artikel online veröffentlicht:
12. August 2021
© 2018. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
-
References
- 1 Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 2017; 70: 252-89
- 2 Jing Z, Yanping L. Middle cerebral artery thrombosis after IVF and ovarian hyperstimulation: A case report. Fertil Steril 2011;95:2435.e13-5.
- 3 Egbe AC, Pislaru SV, Pellikka PA, Poterucha JT, Schaff HV, Maleszewski JJ. et al. Bioprosthetic valve thrombosis versus structural failure: Clinical and echocardiographic predictors. J Am Coll Cardiol 2015; 66: 2285-94
- 4 Butnaru A, Shaheen J, Tzivoni D, Tauber R, Bitran D, Silberman S. et al. Diagnosis and treatment of early bioprosthetic malfunction in the mitral valve position due to thrombus formation. Am J Cardiol 2013; 112: 1439-44
- 5 Oliver JM, Gallego P, Gonzalez A, Dominguez FJ, Gamallo C, Mesa JM. et al. Bioprosthetic mitral valve thrombosis: Clinical profile, transesophageal echocardiographic features, and follow-up after anticoagulant therapy. J Am Soc Echocardiogr 1996; 9: 691-9
- 6 Puri R, Auffret V, Rodés-Cabau J. Bioprosthetic valve thrombosis. J Am Coll Cardiol 2017; 69: 2193-211
- 7 Laschinger JC, Wu C, Ibrahim NG, Shuren JE. Reduced leaflet motion in bioprosthetic aortic valves – the FDA perspective. N Engl J Med 2015; 373: 1996-8
- 8 Pislaru SV, Hussain I, Pellikka PA, Maleszewski JJ, Hanna RD, Schaff HV. et al. Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: Lessons from a case series. Eur J Cardiothorac Surg 2015; 47: 752-32
- 9 Butnaru A, Shaheen J, Tzivoni D, Tauber R, Bitran D, Silberman S. et al. Diagnosis and treatment of early bioprosthetic malfunction in the mitral valve position due to thrombus formation. Am J Cardiol 2013; 112: 1439-44
- 10 Udell JA, Lu H, Redelmeier DA. Long-term cardiovascular risk in women prescribed fertility therapy. J Am Coll Cardiol 2013; 62: 1704-12
- 11 Sennström M, Rova K, Hellgren M, Hjertberg R, Nord E, Thurn L. et al. Thromboembolism and in vitro fertilization – A systematic review. Acta Obstet Gynecol Scand 2017; 96: 1045-52